| scholarly article | Q13442814 |
| P2093 | author name string | Cheresh DA | |
| Piulats J | |||
| Brooks PC | |||
| Montgomery AM | |||
| Strömblad S | |||
| von Schalscha TL | |||
| Petitclerc E | |||
| Mitjans F | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2724-2730 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival | |
| P478 | volume | 59 |
| Q35212620 | A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma |
| Q39618117 | Anoikis induction and metastasis suppression by a new integrin αvβ3 inhibitor in human melanoma cell line M21. |
| Q35157406 | Assembly, stability and integrity of basement membranes in vivo |
| Q93020278 | CAR T cells targeting αvβ3 integrin are effective against advanced cancer in preclinical models |
| Q49952398 | CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling. |
| Q28588612 | Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo |
| Q42776385 | Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). |
| Q26771417 | Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 |
| Q37396761 | Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1 |
| Q47095372 | Deoxycholic acid promotes development of gastroesophageal reflux disease and Barrett's oesophagus by modulating integrin-αv trafficking |
| Q27000037 | Disintegrins from snake venoms and their applications in cancer research and therapy |
| Q37786073 | Dynamic interplay between the collagen scaffold and tumor evolution |
| Q29620360 | How matrix metalloproteinases regulate cell behavior |
| Q26767150 | Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis |
| Q42735424 | Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope |
| Q35088252 | Inhibition of experimental metastasis by targeting the HUIV26 cryptic epitope in collagen |
| Q36579468 | Insulin-like growth factor (IGF) signaling requires αvβ3-IGF1-IGF type 1 receptor (IGF1R) ternary complex formation in anchorage independence, and the complex formation does not require IGF1R and Src activation |
| Q36322769 | Integrin alphav-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen |
| Q24306175 | Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF |
| Q34781192 | Integrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1. |
| Q38696359 | Integrin β3/Akt signaling contributes to platelet-induced hemangioendothelioma growth. |
| Q33591910 | Integrins as "functional hubs" in the regulation of pathological angiogenesis |
| Q53714956 | Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma. |
| Q29614536 | Integrins in cancer: biological implications and therapeutic opportunities |
| Q36990701 | Issues affecting molecular staging in the management of patients with melanoma |
| Q34418625 | Localizing matrix metalloproteinase activities in the pericellular environment |
| Q35789179 | Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis |
| Q37244724 | Melanoma and the tumor microenvironment |
| Q89967618 | Melanoma in the Eyes of Mechanobiology |
| Q33685302 | N-myc downstream-regulated gene 1 inhibits the proliferation and invasion of hepatocellular carcinoma cells via the regulation of integrin β3 |
| Q30542102 | Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas |
| Q36111439 | Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models. |
| Q35605710 | Orally active αvβ3 integrin inhibitor MK-0429 reduces melanoma metastasis |
| Q34689304 | Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors. |
| Q42093246 | Phosphorylation of focal adhesion kinase (FAK) on Ser732 is induced by rho-dependent kinase and is essential for proline-rich tyrosine kinase-2-mediated phosphorylation of FAK on Tyr407 in response to vascular endothelial growth factor |
| Q34061211 | Potential future clinical applications for the GPIIb/IIIa antagonist, abciximab in thrombosis, vascular and oncological indications |
| Q39429469 | Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review |
| Q36215857 | Protein kinase Cα (PKCα) regulates p53 localization and melanoma cell survival downstream of integrin αv in three-dimensional collagen and in vivo |
| Q36376907 | Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo |
| Q35083731 | Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo |
| Q53339931 | RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells. |
| Q33359281 | Role of caveolin 1, E-cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells |
| Q37440409 | Stamping vital cells - a force-based ligand receptor assay |
| Q33315713 | Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets |
| Q36952077 | Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers. |
| Q38718291 | Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model. |
| Q39026853 | TGF-β-induced (TGFBI) protein in melanoma: a signature of high metastatic potential |
| Q39635152 | Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging |
| Q39928463 | The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation. |
| Q47404782 | The role of Bcl-2 family members in the progression of cutaneous melanoma |
| Q36322653 | The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells |
| Q39177033 | Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation |
| Q42728162 | Tumor angiogenesis: putting a value on plastic GEMMs |
| Q24650026 | Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer |
| Q28512977 | Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development |
| Q35562019 | Ultrasmall integrin-targeted silica nanoparticles modulate signaling events and cellular processes in a concentration-dependent manner |
| Q37712358 | Urokinase-controlled tumor penetrating peptide |
| Q35099507 | Vinculin activators target integrins from within the cell to increase melanoma sensitivity to chemotherapy. |
| Q28345275 | cis Interaction of the cell adhesion molecule CEACAM1 with integrin beta(3) |
| Q58546247 | αvβ3 Integrin is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26 |
Search more.